Aviso: Este site agrega dados públicos oficiais da FDA, ClinicalTrials.gov, PubMed e SEC EDGAR apenas para referência geral. Não constitui aconselhamento médico, diagnóstico, recomendação de tratamento ou aconselhamento de investimento.

PubMed

Print Me an Organ? Ethical and Regulatory Issues Emerging from 3D Bioprinting in Medicine.

PMID: 28185142 ·

F, r, e, d, e, r, i, c, , G, i, l, b, e, r, t, ;, , C, a, t, h, a, l, , D, , O, ', C, o, n, n, e, l, l, ;, , T, a, j, a, n, k, a, , M, l, a, d, e, n, o, v, s, k, a, ;, , S, u, s, a, n, , D, o, d, d, s

RevistaScience and engineering ethics
Ano
PMID28185142

Resumo

Recent developments of three-dimensional printing of biomaterials (3D bioprinting) in medicine have been portrayed as demonstrating the potential to transform some medical treatments, including providing new responses to organ damage or organ failure. However, beyond the hype and before 3D bioprinted organs are ready to be transplanted into humans, several important ethical concerns and regulatory questions need to be addressed. This article starts by raising general ethical concerns associated

Fonte oficial

Ver no PubMed →

Dados provenientes do PubMed / NCBI. Para consultar o texto integral e as informações mais recentes, recorra sempre ao registo oficial.

↑